Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Zhenan Zhu

The Inhibition of RANKL-Induced Osteoclastogenesis Through the Suppression of P38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

The Inhibition of Subchondral Bone Lesions Significantly Reversed the Weight-Bearing Deficit and the Overexpression of CGRP in DRG Neurons, GFAP and Iba-1 in the Spinal Dorsal Horn in the Monosodium Iodoacetate Induced Model of Osteoarthritis Pain

PLoS ONE

Multidisciplinary

2013

English

Related publications

Inhibition of Osteoclastogenesis for Periprosthetic Osteolysis Therapy Through the Suppression of P38 Signaling by Fraxetin

International Journal of Molecular Medicine

Medicine

Genetics

2018

English

Lycorine Suppresses RANKL-induced Osteoclastogenesis in Vitro and Prevents Ovariectomy-Induced Osteoporosis and Titanium Particle-Induced Osteolysis in Vivo

Scientific Reports

Multidisciplinary

2015

English

The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-Induced Osteoclastogenesis Through a RANKL-mediated Signaling Pathway

Journal of Biological Chemistry

English

Calcineurin/Nfat Signaling Pathway Mediates Titanium Particle‑induced Inflammation and Osteoclast Formation by Inhibiting RANKL and M‑CSF In?vitro

Molecular Medicine Reports

English

MMP-9 Inhibition Suppresses Wear Debris-Induced Inflammatory Osteolysis Through Downregulation of RANK/RANKL in a Murine Osteolysis Model

International Journal of Molecular Medicine

Medicine

Genetics

2012

English

The USP14–NLRC5 Pathway Inhibits Titanium Particle–induced Osteolysis in Mice by Suppressing NF-κB and PI3K/AKT Activities

Journal of Biological Chemistry

English

Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways

Frontiers in Pharmacology

Pharmacology

2020

English

Embelin Suppresses Osteoclastogenesis Induced by Receptor Activator of NF- B Ligand and Tumor Cells in Vitro Through Inhibition of the NF- B Cell Signaling Pathway

Molecular Cancer Research

English

Artemether Attenuates LPS-induced Inflammatory Bone Loss by Inhibiting Osteoclastogenesis and Bone Resorption via Suppression of MAPK Signaling Pathway

Cell Death and Disease

Molecular Neuroscience

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Zhenan Zhu

The Inhibition of RANKL-Induced Osteoclastogenesis Through the Suppression of P38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis

The Inhibition of Subchondral Bone Lesions Significantly Reversed the Weight-Bearing Deficit and the Overexpression of CGRP in DRG Neurons, GFAP and Iba-1 in the Spinal Dorsal Horn in the Monosodium Iodoacetate Induced Model of Osteoarthritis Pain

Related publications

Inhibition of Osteoclastogenesis for Periprosthetic Osteolysis Therapy Through the Suppression of P38 Signaling by Fraxetin

Lycorine Suppresses RANKL-induced Osteoclastogenesis in Vitro and Prevents Ovariectomy-Induced Osteoporosis and Titanium Particle-Induced Osteolysis in Vivo

The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-Induced Osteoclastogenesis Through a RANKL-mediated Signaling Pathway

Calcineurin/Nfat Signaling Pathway Mediates Titanium Particle‑induced Inflammation and Osteoclast Formation by Inhibiting RANKL and M‑CSF In?vitro

MMP-9 Inhibition Suppresses Wear Debris-Induced Inflammatory Osteolysis Through Downregulation of RANK/RANKL in a Murine Osteolysis Model

The USP14–NLRC5 Pathway Inhibits Titanium Particle–induced Osteolysis in Mice by Suppressing NF-κB and PI3K/AKT Activities

Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways

Embelin Suppresses Osteoclastogenesis Induced by Receptor Activator of NF- B Ligand and Tumor Cells in Vitro Through Inhibition of the NF- B Cell Signaling Pathway

Artemether Attenuates LPS-induced Inflammatory Bone Loss by Inhibiting Osteoclastogenesis and Bone Resorption via Suppression of MAPK Signaling Pathway